Efficacy Study of Epoetin Alfa in Friedreich Ataxia

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

June 30, 2015

Conditions

Friedreich Ataxia

Interventions

DRUG

Epoetin alfa

Epoetin alfa will be administered s.c. at 1200 IU/Kg every 12 weeks

DRUG

Placebo

Trial Locations (3)

Università di Bari, Bari

Dipartimento di Scienze Neurologiche, Napoli

Università la Sapienza, Neurologia C, Rome

All Listed Sponsors

collaborator

Friedreich's Ataxia Research Alliance

OTHER

collaborator

Associazione Italiana per la lotta alle Sindromi Atassiche (AISA)

UNKNOWN

lead

Federico II University

OTHER

NCT01493973 - Efficacy Study of Epoetin Alfa in Friedreich Ataxia | Biotech Hunter | Biotech Hunter